ATyr Pharma Probability of Future Stock Price Finishing Over 1.38
ATyr Pharma's future price is the expected price of ATyr Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ATyr Pharma performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Please specify ATyr Pharma's target price for which you would like ATyr Pharma odds to be computed.
ATyr |
ATyr Pharma Target Price Odds to finish over 1.38
The tendency of ATyr Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 1.38 or more in 90 days |
| 0.00 | 90 days | 1.38 | about 84.13 |
Based on a normal probability distribution, the odds of ATyr Pharma to move over $ 1.38 or more in 90 days from now is about 84.13 (This ATyr Pharma probability density function shows the probability of ATyr Stock to fall within a particular range of prices over 90 days) . Probability of ATyr Pharma price to stay between its current price of $ 0.00 and $ 1.38 at the end of the 90-day period is about 15.85 .
Given the investment horizon of 90 days ATyr Pharma has a beta of 0.14. This indicates as returns on the market go up, ATyr Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ATyr Pharma will be expected to be much smaller as well. Additionally ATyr Pharma has an alpha of 0.3937, implying that it can generate a 0.39 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). ATyr Pharma Price Density |
| Price |
Predictive Modules for ATyr Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ATyr Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ATyr Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ATyr Pharma is not an exception. The market had few large corrections towards the ATyr Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ATyr Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ATyr Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.39 | |
β | Beta against Dow Jones | 0.14 | |
σ | Overall volatility | 0.34 | |
Ir | Information ratio | 0.09 |
ATyr Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ATyr Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ATyr Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ATyr Pharma is now traded under the symbol ATYR. Please update your portfolios or report it if you believe this is an error. Report It! | |
| ATyr Pharma is not yet fully synchronised with the market data | |
| ATyr Pharma has some characteristics of a very speculative penny stock | |
| ATyr Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 353 K. Net Loss for the year was (50.39 M) with loss before overhead, payroll, taxes, and interest of (32.42 M). | |
| ATyr Pharma currently holds about 88.55 M in cash with (33.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09. | |
| Roughly 62.0% of the company shares are owned by institutional investors |
ATyr Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ATyr Stock often depends not only on the future outlook of the current and potential ATyr Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ATyr Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.6 M | |
| Cash And Short Term Investments | 98.2 M |
ATyr Pharma Technical Analysis
ATyr Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. ATyr Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ATyr Pharma. In general, you should focus on analyzing ATyr Stock price patterns and their correlations with different microeconomic environments and drivers.
ATyr Pharma Predictive Forecast Models
ATyr Pharma's time-series forecasting models is one of many ATyr Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ATyr Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ATyr Pharma
Checking the ongoing alerts about ATyr Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ATyr Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ATyr Pharma is now traded under the symbol ATYR. Please update your portfolios or report it if you believe this is an error. Report It! | |
| ATyr Pharma is not yet fully synchronised with the market data | |
| ATyr Pharma has some characteristics of a very speculative penny stock | |
| ATyr Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 353 K. Net Loss for the year was (50.39 M) with loss before overhead, payroll, taxes, and interest of (32.42 M). | |
| ATyr Pharma currently holds about 88.55 M in cash with (33.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09. | |
| Roughly 62.0% of the company shares are owned by institutional investors |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in ATyr Stock
If you are still planning to invest in ATyr Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATyr Pharma's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |